beta-amyloid pathology is not associated with depression in a large community sample autopsy study

Imagem de Miniatura
Arquivos
art_SALDANHA_betaamyloid_pathology_is_not_associated_with_depression_in_2021.PDF (842.42 KB)
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
SILVA, Magnolia Moreira da
Citação
JOURNAL OF AFFECTIVE DISORDERS, v.278, p.372-381, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: : Depression has been associated with dementia. This study aimed to verify if 13-amyloid Alzheimer's disease-type burden was associated with lifetime major depressive disorder (MDD) and with current depressive symptoms in a large population-based autopsy study. Methods: : We included 1013 deceased subjects submitted to autopsy (mean age=74.3 +/- 11.6 years, 49% men) in a community sample. 13-amyloid burden was measured in all cases based on the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) criteria for presence and density of neuritic plaques. Lifetime MDD was defined when at least one previous episode according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders - DSM (SCID). Depressive symptoms and cognitive impairment were determined using the depression item of the Neuropsychiatric Inventory (D-NPI>0) and the Clinical Dementia Rating scale (CDR>0.5) respectively. Results: : Lifetime MDD, late life depression (LLD) and current depressive symptoms were associated with cognitive impairment (p<0.001). Additionally, neuritic plaques were associated with cognitive impairment (p<0.001). Moderate or frequent neurite plaque density was not associated with MDD, LLD or current depressive symptoms in multiple logistic models adjusted for age, gender, and cognitive impairment. Limitations:: In this cross-sectional study, all neuropsychiatric and cognitive assessment were based on informant-report of deceased participants. Conclusions: : Different clinical depictions of depression were associated with dementia in this large community sample of elderly individuals with multiethnic backgrounds. Notwithstanding, they were unrelated to 13-amyloid pathology in the brain areas studied. The link between depression and dementia might be complex and determined by multiple factors.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/39738
Referências
  1. Almeida OP, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.90
  2. Babulal GM, 2016, AM J GERIAT PSYCHIAT, V24, P1095, DOI 10.1016/j.jagp.2016.04.004
  3. Barnes DE, 2012, ARCH GEN PSYCHIAT, V69, P493, DOI 10.1001/archgenpsychiatry.2011.1481
  4. Borza Tom, 2019, Tidsskr Nor Laegeforen, V139, DOI 10.4045/tidsskr.18.0968
  5. Brendel M, 2015, EUR J NUCL MED MOL I, V42, P716, DOI 10.1007/s00259-014-2975-4
  6. Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60
  7. Canet G, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00739
  8. Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022
  9. Charlton RA, 2018, INT J GERIATR PSYCH, V33, P104, DOI 10.1002/gps.4686
  10. Chung JK, 2016, J GERIATR PSYCH NEUR, V29, P149, DOI 10.1177/0891988715606230
  11. Chung JK, 2015, J ALZHEIMERS DIS, V45, P907, DOI 10.3233/JAD-142931
  12. Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S
  13. DaRocha-Souto B, 2011, J NEUROPATH EXP NEUR, V70, P360, DOI 10.1097/NEN.0b013e318217a118
  14. DeTure MA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0333-5
  15. Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307
  16. Diniz BS, 2011, NEUROMOL MED, V13, P217, DOI 10.1007/s12017-011-8154-x
  17. Donohue MC, 2017, JAMA-J AM MED ASSOC, V317, P2305, DOI 10.1001/jama.2017.6669
  18. Donovan NJ, 2016, JAMA PSYCHIAT, V73, P1230, DOI 10.1001/jamapsychiatry.2016.2657
  19. Donovan NJ, 2015, J ALZHEIMERS DIS, V46, P63, DOI 10.3233/JAD-142940
  20. Ehrenberg AJ, 2018, J ALZHEIMERS DIS, V66, P115, DOI 10.3233/JAD-180688
  21. Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011
  22. Ferretti-Rebustini Renata Eloah de Lucena, 2015, Dement. neuropsychol., V9, P103, DOI 10.1590/1980-57642015DN92000004
  23. do Nascimento KKF, 2015, J PSYCHIATR RES, V69, P35, DOI 10.1016/j.jpsychires.2015.07.024
  24. Frozza RL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00037
  25. Funaki K, 2019, PSYCHOGERIATRICS, V19, P325, DOI 10.1111/psyg.12397
  26. Gatchel JR, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8964
  27. Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01
  28. GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106
  29. Greenberg SM, 2020, NAT REV NEUROL, V16, P30, DOI 10.1038/s41582-019-0281-2
  30. Grinberg LT, 2013, CLINICS, V68, P1140, DOI 10.6061/clinics/2013(08)13
  31. Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
  32. HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V
  33. Harrington Karra D, 2017, Alzheimers Dement (Amst), V8, P156, DOI 10.1016/j.dadm.2017.05.006
  34. Harrington KD, 2015, AUST NZ J PSYCHIAT, V49, P36, DOI 10.1177/0004867414557161
  35. Harrison JK, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011333.pub2
  36. Hughes TM, 2012, J ALZHEIMERS DIS, V30, P53, DOI 10.3233/JAD-2012-111460
  37. Ishijima S, 2018, PSYCHIAT RES, V259, P191, DOI 10.1016/j.psychres.2017.10.008
  38. Ismail Z, 2018, INT PSYCHOGERIATR, V30, P185, DOI 10.1017/S1041610217001880
  39. James BD, 2019, ANNU REV PUBL HEALTH, V40, P65, DOI 10.1146/annurev-publhealth-040218-043758
  40. JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X
  41. Kametani F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00025
  42. Kapasi A, 2017, ACTA NEUROPATHOL, V134, P171, DOI 10.1007/s00401-017-1717-7
  43. Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505
  44. Kaup AR, 2016, JAMA PSYCHIAT, V73, P525, DOI 10.1001/jamapsychiatry.2016.0004
  45. Kim HK, 2016, PROG NEURO-PSYCHOPH, V67, P51, DOI 10.1016/j.pnpbp.2016.01.008
  46. Knopman DS, 2013, ANN NEUROL, V73, P472, DOI 10.1002/ana.23816
  47. Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106
  48. Koyama A, 2012, ARCH NEUROL-CHICAGO, V69, P824, DOI 10.1001/archneurol.2011.1841
  49. Krell-Roesch J, 2018, INT PSYCHOGERIATR, V30, P245, DOI 10.1017/S1041610217002368
  50. Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168
  51. Leggett A, 2013, AGING MENT HEALTH, V17, P915, DOI 10.1080/13607863.2013.799116
  52. Li P, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0273-4
  53. Li XL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/927804
  54. Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6
  55. Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475
  56. Madsen K, 2012, NEUROBIOL AGING, V33, P2334, DOI 10.1016/j.neurobiolaging.2011.11.021
  57. Mahgoub N, 2016, AM J GERIAT PSYCHIAT, V24, P239, DOI 10.1016/j.jagp.2015.12.003
  58. Masters MC, 2015, NEUROLOGY, V84, P617, DOI 10.1212/WNL.0000000000001238
  59. McCutcheon ST, 2016, INT J GERIATR PSYCH, V31, P1301, DOI 10.1002/gps.4435
  60. MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479
  61. Mirza P, 2014, 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: STUDENT RESEARCH WORKSHOP (ACL 2014), P10
  62. MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
  63. NAGY Z, 1995, NEUROSCIENCE, V69, P757, DOI 10.1016/0306-4522(95)00331-C
  64. Nitsch RM, 1996, J BIOL CHEM, V271, P4188
  65. Norton J, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0620-5
  66. Nunes PV, 2019, J ALZHEIMERS DIS, V68, P669, DOI 10.3233/JAD-180641
  67. Nunes PV, 2018, J AFFECT DISORDERS, V241, P176, DOI 10.1016/j.jad.2018.08.025
  68. Okamura N, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0500-6
  69. Perin S, 2018, J AFFECT DISORDERS, V229, P269, DOI 10.1016/j.jad.2017.12.101
  70. Perini G, 2019, NEUROPSYCH DIS TREAT, V15, P1249, DOI 10.2147/NDT.S199746
  71. Peters ME, 2013, AM J GERIAT PSYCHIAT, V21, P1116, DOI 10.1016/j.jagp.2013.01.049
  72. Pinheiro L, 2019, CURR ALZHEIMER RES, V16, P418, DOI 10.2174/1567205016666190321163438
  73. Pomara N, 2012, AM J PSYCHIAT, V169, P523, DOI 10.1176/appi.ajp.2011.11081153
  74. Qiu WQ, 2016, INT J GERIATR PSYCH, V31, P316, DOI 10.1002/gps.4339
  75. Rapp MA, 2006, ARCH GEN PSYCHIAT, V63, P161, DOI 10.1001/archpsyc.63.2.161
  76. Rapp MA, 2008, AM J GERIAT PSYCHIAT, V16, P168, DOI 10.1097/JGP.0b013e31816029ec
  77. Roca M, 2015, ACTAS ESP PSIQUIATRI, V43, P187
  78. Royall DR, 2013, ALZHEIMERS DEMENT, V9, P318, DOI 10.1016/j.jalz.2011.11.009
  79. Saczynski JS, 2015, AM J MED, V128, P739, DOI 10.1016/j.amjmed.2015.01.007
  80. Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
  81. SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2
  82. Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777
  83. Singh-Manoux A, 2017, JAMA PSYCHIAT, V74, P712, DOI 10.1001/jamapsychiatry.2017.0660
  84. Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003
  85. Spitzer R, 1995, STRUCTURED CLIN INTE
  86. Suemoto CK, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002267
  87. Tapiainen V, 2017, EUR PSYCHIAT, V43, P92, DOI 10.1016/j.eurpsy.2017.02.486
  88. Taylor WD, 2017, AM J PSYCHIAT, V174, P197, DOI 10.1176/appi.ajp.2016.16111317
  89. TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
  90. Theofilas P, 2015, J ALZHEIMERS DIS, V46, P17, DOI 10.3233/JAD-142682
  91. Tsopelas C, 2011, BRIT J PSYCHIAT, V198, P109, DOI 10.1192/bjp.bp.110.078816
  92. Tsuruga K, 2014, NEUROPSYCH DIS TREAT, V10, P1621, DOI [10.2147/NDT.567205, 10.2147/NDT.S67205]
  93. Vogel JW, 2017, NEUROLOGY, V89, P2002, DOI [10.1212/wnl.0000000000004627, 10.1212/WNL.0000000000004627]
  94. Wilson RS, 2016, NEUROPSYCHOLOGY, V30, P135, DOI 10.1037/neu0000223
  95. Wilson RS, 2014, NEUROLOGY, V83, P702, DOI 10.1212/WNL.0000000000000715
  96. Wilson RS, 2003, NEUROLOGY, V61, P1102, DOI 10.1212/01.WNL.0000092914.04345.97
  97. Wu KY, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1016
  98. Wu KY, 2016, EUR J NUCL MED MOL I, V43, P1067, DOI 10.1007/s00259-015-3291-3
  99. Wu KY, 2014, EUR J NUCL MED MOL I, V41, P714, DOI 10.1007/s00259-013-2627-0
  100. Yeh YC, 2011, AM J GERIAT PSYCHIAT, V19, P923, DOI 10.1097/JGP.0b013e318202clc6
  101. Zahodne LB, 2015, AM J GERIAT PSYCHIAT, V23, P130, DOI 10.1016/j.jagp.2013.03.014
  102. Zheng WH, 2002, NEUROSCIENCE, V115, P201, DOI 10.1016/S0306-4522(02)00404-9

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IPq
Carregar mais